Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers. - Wikidata - wikimedia - TriplyDB

Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.

Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.

http://www.wikidata.org/entity/Q40310120

about

The 5'UTR in human adenoviruses: leader diversity in late gene expression.The Antiviral Effect of High-Molecular Weight Poly-Gamma-Glutamate against Newcastle Disease Virus on Murine Macrophage Cells.Antiviral Effects of Novel Herbal Medicine KIOM-C, on Diverse Viruses.Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.Adeno-associated virus enhances wild-type and oncolytic adenovirus spread.iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy.The combination of i-leader truncation and gemcitabine improves oncolytic adenovirus efficacy in an immunocompetent model.RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion.Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.Oncolytic Adenoviruses in Cancer Treatment.

P2860

Q33677430-33AD88CE-670B-4FB2-A6FE-8DD75E42E588 Q34951570-EB894E25-15DE-463C-B4FC-9BFCB12775CC Q35571112-DC6F50B4-445F-41D1-A944-2BD2260021F9 Q36757082-D453CBB9-ECB3-454A-B2E9-D20881B4735D Q37406907-0AC22492-DD09-4A7A-BD1D-208CC4E14CC3 Q38983280-74A4D30B-AE6E-47DD-B1AD-61D011421306 Q39033731-2C4661FE-BC64-4292-A561-F1C9A3902BEF Q41084014-CE92AD5A-2115-4DBD-B3A5-58AD9B00C3C4 Q47705730-1E631448-F954-41AA-9C68-83B5EEE82CCE Q51849210-B5A4FEB2-580B-45B0-8636-38EDA779400D

P2860

Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.

http://www.wikidata.org/entity/Q40310120

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Adenovirus i-leader truncation ...... ercome tumor stromal barriers.

@en

type

label

Adenovirus i-leader truncation ...... ercome tumor stromal barriers.

@en

prefLabel

Adenovirus i-leader truncation ...... ercome tumor stromal barriers.

@en

P1433

Q40310120-32D08359-D40E-4722-99A1-112711364066

P1476

Q40310120-11ADF25B-0401-418A-A63A-BCAD32F205A1

P2093

Q40310120-25DC4E9F-C01E-44A9-A20E-9EC9077FFB9F

Q40310120-A918E3D3-3BA5-4AD5-A886-5CD4EBE7A22A

Q40310120-ED17F978-D465-4797-81D5-6EFD03A4E03E

P2860

Q40310120-0183F84F-FC2C-45F8-B130-E7E38D421B3D

Q40310120-06513D0E-8B75-4F2D-90E2-796868C275ED

Q40310120-06AFF4C7-9970-4BC1-9859-F65A6C76C686

Q40310120-08A530B4-03F0-455C-9559-32668B0CAD1F

Q40310120-12D62346-A1FB-4A11-8523-580701926E67

Q40310120-13684C99-18AF-41D0-8099-4C4E638A7DDC

Q40310120-159B3E31-AE30-420C-BA3F-EF720BD0A421

Q40310120-17B904FF-27A9-4001-BD0F-5FF62A71A1CA

Q40310120-21BABF25-5273-4F41-B711-AA03063C9B7F

Q40310120-21D6C99C-A42A-4EA9-B841-192D1C346FE8

P304

Q40310120-F79434E8-64FE-46C1-9239-29E24097CAF6

P31

Q40310120-E8EDC12A-8A7B-46FA-BE19-F514EC707A93

P356

Q40310120-6BCC5C01-0B99-4F1D-A7C4-50917BDCF94C

P433

Q40310120-E0757AE1-2BAB-47BA-9E9B-A27A686246B2

P478

Q40310120-F508704E-09CF-4AF2-9D84-4BC8F4A8B584

P50

Q40310120-0129C2BD-9397-489C-A02A-3D234658E932

P577

Q40310120-58A51963-11F8-4DA2-804E-F8743821FB3E

P5875

Q40310120-CE5898DE-005A-4EA8-9D8A-E339BF6AEA97

P698

Q40310120-99C69C84-38C1-4576-A043-A850D2EDB374

P921

Q40310120-D4CBDBDE-AD23-416A-915B-AB144313109B

P932

Q40310120-527E28A0-1916-455A-A5AE-022053CDAC82

P356

P1433

Molecular Therapy

P1476

Adenovirus i-leader truncation ...... ercome tumor stromal barriers.

@en

P2093

Cristina Puig-Saus

http://www.w3.org/2001/XMLSchema#string

Manel Cascalló

http://www.w3.org/2001/XMLSchema#string

Ramon Alemany

http://www.w3.org/2001/XMLSchema#string

P2860

Fibroblasts in cancer

A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.

Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses

Current issues and future directions of oncolytic adenoviruses.

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth.

Genetic identification of adenovirus type 5 genes that influence viral spread.

Developing novel oncolytic adenoviruses through bioselection

Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop.

P304

54-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2011.159

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51591607

http://www.w3.org/2001/XMLSchema#string

P698

21863000

http://www.w3.org/2001/XMLSchema#string

P921

P932

3255593

http://www.w3.org/2001/XMLSchema#string